Mkts

ADC Therapeutics SA

NYSE: ADCT
$1.34-0.07 (-4.96%)
As of Nov 13, 4:00 PM ET

Key statistics

Day range
1.281.43
52-week range
0.784.98
Today
Open1.41
Previous close1.34
Volume25.1K
Valuation
Market cap171.07M
P/E ratio—
EPS (TTM)-0.73
Income & risk
Dividend / yield—
Beta1.86
Avg volume1.44M
Discussion

ADCT News

Stories mentioning ADCT from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue20,03330,11815,75018,08517,40417,94318,01617,030
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development19,87718,18426,80330,09028,92827,10132,50224,295
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)(25,245)(17,919)(30,969)(44,147)(28,464)(32,436)(35,564)(29,041)
Interest Income1,9942,3522,4701,9342,0542,6333,4383,253
Interest Expense12,23011,91913,11712,679
Other Expense2,63221,768925.00(182.00)203.0010,6741,6242,754
Pretax Income(32,968)(38,437)
Tax Provision0.00(404.00)0.001,254165.00(321.00)90.00234.00
Net Income (Loss)(32,968)(6,409)(40,966)(56,646)(38,602)(30,727)(43,969)(36,544)
Earnings Per Share (Basic)(0.21)(0.05)(0.30)(0.50)(0.36)(0.32)(0.42)(0.38)
Earnings Per Share (Diluted)(0.21)(0.05)(0.30)(0.50)(0.36)(0.32)(0.42)(0.38)
Weighted Average Shares Outstanding (Basic)154,142127,068136,447113,743107,20297,160104,82595,691
Weighted Average Shares Outstanding (Diluted)154,142127,068136,447113,743107,20297,160104,82595,691

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ADCT

ADC Therapeutics SA (NYSE: ADCT) is a stock listed on the New York Stock Exchange under the ticker symbol ADCT. It last traded at $1.34 (Nov 13, 2026, 4:00 PM ET), down 5.0% on the day. That gives ADC Therapeutics a market capitalisation of $171.1M.

Over the past 52 weeks ADCT has traded between $0.7800 and $4.98.

Revenue for the quarter ended Mar 31, 2026 was $20.0M; a net loss of $33.0M. Revenue was up 15.1% from $17.4M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$20.0M-$33.0M-164.6%
Dec 31, 2025$30.1M-$6.4M-21.3%
Sep 30, 2025$15.8M-$41.0M-260.1%
Jun 30, 2025$18.1M-$56.6M-313.2%

From ADC Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…